-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
Case report
(1821) Views (420) Full article downloads
Authors: Hideki Ishida, Kazunari Tanabe
Published Date June 2008
Volume 2008:4(3) Pages 641 - 644
DOI: http://dx.doi.org/10.2147/TCRM.S2499
Hideki Ishida, Kazunari Tanabe
Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan
Abstract: A patient showing antibody-mediated rejection (AMR) with severe vasculitis, and massive proteinuria after kidney transplantation was treated with deoxyspergualine (DSG, Spanidin®, Nippon Kayaku). DSG showed marked efficacy for this patient’s symptoms. We report on a patient for whom DSG was effective against AMR after renal transplantation.
Keywords: deoxyspergualine (DSG), vascular rejection, antihuman leukocyte antigen (HLA) antibody
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
